Cypress Capital Group Zoetis Inc. Transaction History

Cypress Capital Group

$828 Million
Q1 2024

A detailed history of Cypress Capital Group transactions in Zoetis Inc. stock. As of the latest transaction made, Cypress Capital Group holds 17,869 shares of ZTS stock, worth $3.13 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

17,869

Previous 17,811 0.33%

Holding current value

$3.13 Million

Previous $3.52 Million 14.0%

% of portfolio

0.36%

Previous 0.46%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$165.67 - $199.94 $9,608 - $11,596	58 Added 0.33%	17,869 $3.02 Million
Q4 2023 Jan 24, 2024	SELL	$151.44 - $200.09 $45,432 - $60,027	-300 Reduced 1.66%	17,811 $3.52 Million
Q3 2023 Nov 02, 2023	SELL	$167.14 - $192.77 $21,895 - $25,252	-131 Reduced 0.72%	18,111 $3.15 Million
Q2 2023 Jul 26, 2023	SELL	$160.94 - $186.23 $115,072 - $133,154	-715 Reduced 3.77%	18,242 $3.14 Million
Q1 2023 May 04, 2023	SELL	$145.48 - $175.02 $34,624 - $41,654	-238 Reduced 1.24%	18,957 $3.16 Million

Q4 2022 Feb 14, 2023	SELL	$131.14 - $157.47 $324,046 - $389,108	-2,471 Reduced 11.4%	19,195 $2.81 Million
Q3 2022 Nov 04, 2022	SELL	$148.29 - $182.55 $533,844 - $657,180	-3,600 Reduced 14.25%	21,666 $3.21 Million
Q2 2022 Jul 26, 2022	SELL	$155.97 - $200.09 $218,358 - $280,126	-1,400 Reduced 5.25%	25,266 $4.34 Million
Q1 2022 May 16, 2022	SELL	$181.39 - $234.03 $206,059 - $265,858	-1,136 Reduced 4.09%	26,666 $5.03 Million
Q4 2021 Feb 15, 2022	SELL	$193.69 - $247.03 $501,657 - $639,807	-2,590 Reduced 8.52%	27,802 $6.79 Million
Q3 2021 Oct 12, 2021	BUY	$189.29 - $209.69 $139,506 - $154,541	737 Added 2.49%	30,392 $5.9 Million
Q2 2021 Jul 13, 2021	BUY	$155.9 - $187.99 $61,424 - $74,068	394 Added 1.35%	29,655 $5.53 Million
Q1 2021 Apr 14, 2021	BUY	$144.0 - $169.39 $58,032 - $68,264	403 Added 1.4%	29,261 $4.61 Million
Q4 2020 Jan 12, 2021	BUY	$157.07 - $174.35 $542,833 - $602,553	3,456 Added 13.61%	28,858 $4.78 Million
Q3 2020 Oct 08, 2020	SELL	$137.1 - $165.37 $142,309 - $171,654	-1,038 Reduced 3.93%	25,402 $4.2 Million
Q2 2020 Jul 10, 2020	BUY	$111.92 - $142.53 $113,486 - $144,525	1,014 Added 3.99%	26,440 $3.62 Million
Q1 2020 Apr 08, 2020	SELL	$92.66 - $144.94 $54,762 - $85,659	-591 Reduced 2.27%	25,426 $2.99 Million
Q4 2019 Jan 10, 2020	BUY	$116.25 - $133.25 $232,267 - $266,233	1,998 Added 8.32%	26,017 $3.44 Million
Q3 2019 Oct 10, 2019	BUY	$112.57 - $128.43 $301,124 - $343,550	2,675 Added 12.53%	24,019 $2.99 Million
Q2 2019 Aug 15, 2019	BUY	$97.98 - $114.28 $313,046 - $365,124	3,195 Added 17.6%	21,344 $2.42 Million
Q1 2019 May 14, 2019	SELL	$81.56 - $100.67 $155,616 - $192,078	-1,908 Reduced 9.51%	18,149 $1.83 Million
Q4 2018 Feb 19, 2019	SELL	$79.28 - $95.27 $257,739 - $309,722	-3,251 Reduced 13.95%	20,057 $1.72 Million
Q3 2018 Nov 15, 2018	BUY	$83.5 - $93.23 $403,388 - $450,394	4,831 Added 26.15%	23,308 $2.13 Million
Q2 2018 Aug 15, 2018	BUY	$79.9 - $89.2 $1.48 Million - $1.65 Million	18,477 New	18,477 $1.57 Million

Others Institutions Holding ZTS

# of Institutions

1,861

Shares Held

416M

Call Options Held

1.13M

Put Options Held

1.81M

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $82.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.

Account

Cypress Capital Group Zoetis Inc. Transaction History